Berlin Cures will reveal the results of the BC007 Phase II trial in November at a Long Covid conference.
https://www.berlincures.com/en/news/demystifying-long-covid-interntaional-conference-2024
"Dr. Oliver von Stein, CEO, and Dr. Axel Mescheder, CMO, will represent Berlin Cures at the event...